Roche chases stake in medical sequencing

Erika Check Hayden

Nature, 2012, vol. 484, issue 7393, 152-152

Abstract: Biotech firm Illumina continues to resist takeover — but analysts suggest that a merger is inevitable.

Date: 2012
References: Add references at CitEc
Citations:

Downloads: (external link)
https://www.nature.com/articles/484152a Abstract (text/html)
Access to the full text of the articles in this series is restricted.

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:nat:nature:v:484:y:2012:i:7393:d:10.1038_484152a

Ordering information: This journal article can be ordered from
https://www.nature.com/

DOI: 10.1038/484152a

Access Statistics for this article

Nature is currently edited by Magdalena Skipper

More articles in Nature from Nature
Bibliographic data for series maintained by Sonal Shukla () and Springer Nature Abstracting and Indexing ().